[NKTR] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -3.34%
YoY- -19.45%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 21,585 24,822 25,009 24,921 28,330 23,647 23,462 -5.42%
PBT -158,968 -90,267 -145,649 -129,594 -125,162 -122,875 -117,075 22.68%
Tax 100 126 -4 112 357 92 128 -15.21%
NP -159,068 -90,393 -145,645 -129,706 -125,519 -122,967 -117,203 22.65%
Tax Rate - - - - - - - -
Total Cost 180,653 115,215 170,654 154,627 153,849 146,614 140,665 18.20%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -736.94 -364.16 -582.37 -520.47 -443.06 -520.01 -499.54 29.68%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.85 -0.49 -0.79 -0.70 -0.69 -0.68 -0.65 19.64%
EPS Diluted -0.85 -0.49 -0.79 -0.70 -0.69 -0.68 -0.65 19.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.